VIEMED HEALTHCARE, INC.

VMD

VIEMED HEALTHCARE, INC.

VMD

Insider Sentiment (TTM):

Last Purchase:2024-05-14Last Sale:2026-06-25Shares Purchased (TTM):0Shares Sold (TTM):125,202

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:24,243,595Shares Outstanding:38,428,588Institutional Ownership Pct.:63.09%

Earnings Market Reaction:

Filing Date:2026-05-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Misc Health & Allied Services, NEC

DVA SHC PGNY AGL PARK CCEL

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	10	14	11	20	10	18	11	9	7	13	10	10
Accounts Receivable Net Current	31	26	27	27	27	25	27	27	24	18	18	18
Inventory Net	5	5	5	4	5	4	4	4	4	5	5	4
Income Taxes Receivable	0	0	2	-	-	0	-	0	-	0	0	1
Prepaid Expense And Other Assets Current	4	4	4	4	8	6	5	4	2	2	3	2
Assets Current	50	48	50	55	49	53	48	45	39	38	36	36
Assets Noncurrent
Property Plant And Equipment Net	76	79	81	80	81	76	74	75	74	74	73	73
Finance Lease Right Of Use Asset	-	0	0	0	0	0	0	0	0	0	1	1
Operating Lease Right Of Use Asset	3	4	4	3	3	3	3	3	3	3	0	1
Investments	-	-	-	-	-	-	2	2	2	2	2	2
Equity Securities F V N I Noncurrent	3	3	3	3	3	3	-	-	-	2	-	-
Debt Securities Noncurrent	-	-	-	-	-	0	1	1	2	2	2	2
Deferred Income Tax Assets Net	5	5	6	10	8	8	8	5	5	5	4	4
Intangible Assets Net Excluding Goodwill	1	1	1	1	1	1	1	1	1	1	1	1
Goodwill	59	59	58	33	33	33	33	33	30	30	30	30
Other Assets Noncurrent	-	-	-	-	-	0	0	0	1	1	1	1
Assets Noncurrent	148	151	152	129	129	124	122	119	116	117	114	113
Assets	197	199	202	185	178	177	170	164	155	155	149	149
Liabilities
Liabilities Current
Accounts Payable Trade Current	9	7	9	8	8	5	6	6	6	4	6	6
Contract With Customer Liability Current	7	8	8	7	7	7	7	7	6	6	6	6
Accrued Income Taxes Current	1	0	0	1	2	4	2	0	3	2	0	-
Accrued Liabilities Current	22	24	25	19	18	20	20	17	14	18	17	16
Finance Lease Liability Current	-	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	0	0
Long Term Debt Current	1	1	2	1	0	0	1	1	1	1	2	3
Liabilities Current	41	41	44	37	35	37	36	31	30	32	32	32
Liabilities Noncurrent
Accounts Payable And Accrued Liabilities Noncurren…	0	1	1	1	0	1	1	0	0	1	1	1
Operating Lease Liability Noncurrent	2	2	2	2	2	2	2	2	2	2	0	0
Long Term Debt Noncurrent	8	11	20	3	4	4	4	9	6	6	8	12
Finance Lease Liability Noncurrent	-	-	-	-	-	0	0	0	0	0	0	0
Liabilities Noncurrent	11	15	23	6	6	6	6	11	8	9	9	13
Liabilities	52	56	67	43	41	44	43	43	39	41	41	45
Commitments And Contingencies	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Common Stock Value	21	17	17	28	28	23	23	22	22	19	19	18
Stockholders Equity Inclu…
Additional Paid In Capital Common Stock	18	22	19	18	16	18	17	16	14	16	14	13
Retained Earnings Accumulated Deficit	105	103	97	94	91	90	85	82	80	79	76	73
Stockholders Equity	146	142	135	142	135	133	125	121	116	114	109	105
Minority Interest	2	2	2	2	2	2	2	2	-	0	-	-
Liabilities And Stockholders Equity	197	199	202	185	178	177	170	164	155	155	149	149
Common Stock Shares Issued	39	38	38	40	40	39	39	39	39	39	38	38
Shares Outstanding	39	38	38	40	40	39	39	39	39	39	38	38

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	1.44%	19.90%	-	-	-	-	-	-	-	-	-	-
2025	-8.53%	-4.81%	-15.82%	14.26%	4.03%	7.29%	7.47%	13.53%	13.84%	1.87%	6.39%	6.28%
2024	-9.85%	-20.32%	-9.73%	16.39%	11.64%	41.50%	-5.14%	-10.72%	-7.22%	-7.03%	-0.41%	-10.14%
2023	-9.18%	-9.36%	-16.50%	-2.76%	-19.30%	-27.58%	31.47%	33.44%	27.51%	0.53%	-11.41%	-24.73%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.22	1.18	1.13	1.48	1.38	1.42	1.31	1.43	1.28	1.19	1.14	1.14
Quick Ratio	1.01	0.96	0.92	1.25	1.04	1.14	1.05	1.15	1.06	0.97	0.89	0.92
Working Capital	9.11M	7.44M	5.79M	18.02M	13.63M	15.55M	11.25M	13.50M	8.50M	6.24M	4.31M	4.37M
Leverage & Debt
Debt to Equity	0.35	0.39	0.49	0.30	0.31	0.33	0.34	0.35	0.33	0.36	0.37	0.43
Interest Coverage TTM	14.05	14.90	16.62	21.38	17.68	16.64	21.27	19.17	25.84	30.88	26.98	36.30
Debt Ratio	0.26	0.28	0.33	0.23	0.23	0.25	0.25	0.26	0.25	0.26	0.27	0.30
Efficiency & Turnover
Asset Turnover TTM	1.53	1.44	1.37	1.38	1.40	1.35	1.34	1.31	1.39	1.35	1.26	1.18
Days Sales Outstanding TTM	36.92	34.10	39.01	40.62	40.19	35.29	38.30	39.89	38.37	33.74	35.37	37.61
Receivables Turnover TTM	9.89	10.70	9.36	8.99	9.08	10.34	9.53	9.15	9.51	10.82	10.32	9.70
Per Share Metrics
Diluted EPS TTM	0.38	0.38	0.34	0.34	0.30	0.28	0.26	0.23	0.25	0.25	0.23	0.18
Free Cash Flow Per Share TTM	0.67	0.31	0.14	-0.09	-0.16	0.03	0.09	0.21	0.22	0.50	0.41	0.29
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	57.58%	57.52%	57.89%	58.33%	58.71%	59.40%	60.28%	60.95%	61.11%	61.63%	61.00%	60.63%
Operating Profit Margin TTM	8.17%	8.49%	8.25%	8.72%	8.39%	7.98%	7.81%	7.45%	7.52%	7.83%	7.41%	6.30%
Net Profit Margin TTM	5.35%	5.69%	5.40%	5.86%	5.34%	5.09%	4.87%	4.60%	5.32%	5.60%	5.42%	4.70%
Growth Metrics
Net Revenue Growth (1Y)	23.10%	20.52%	18.90%	17.11%	19.97%	22.54%	26.22%	31.75%	32.79%	31.82%	27.38%	23.12%
Net Income Growth (1Y)	23.34%	34.77%	31.93%	49.15%	20.35%	11.38%	13.28%	28.98%	72.81%	64.63%	16.94%	-14.70%
EPS Growth (1Y)	26.55%	34.28%	32.72%	46.54%	18.18%	10.23%	12.02%	27.32%	70.31%	65.92%	16.31%	-13.70%
Valuation Metrics
P/E TTM	23.08	18.79	19.07	19.34	23.09	27.24	27.33	26.86	35.35	29.39	28.11	51.06
P/B TTM	2.43	2.01	1.94	1.93	2.13	2.33	2.28	2.10	3.14	2.64	2.38	3.59
P/S TTM	1.24	1.07	1.03	1.13	1.23	1.39	1.33	1.24	1.88	1.65	1.52	2.40
Market Cap	353.93M	288.99M	262.36M	273.05M	287.03M	310.81M	284.92M	254.29M	365.10M	301.08M	258.69M	374.81M
Enterprise Value	353.37M	287.87M	272.37M	257.33M	280.82M	297.32M	278.11M	255.08M	364.49M	295.57M	258.87M	380.25M
Calculated Values
Free Cash Flow TTM	25.92M	11.93M	5.39M	-3.60M	-6.48M	1.32M	3.51M	8.18M	8.47M	19.12M	15.88M	11.11M
Net Debt	-557.00K	-1.12M	10.02M	-15.72M	-6.21M	-13.49M	-6.82M	791.00K	-608.00K	-5.51M	184.00K	5.43M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-25Sale

Owner: Frazier, William

Title: Chief Medical Officer

Shares: 10,000

Price/Share: $11.72

Value: $117,200.00

Shares Owned: 73,214

Relationship: Director,Officer

Ownership: Direct

2026-06-24Sale

Owner: Smokoff, Timothy

Title: -

Shares: 20,000

Price/Share: $11.50

Value: $230,000.00

Shares Owned: 75,518

Relationship: Director

Ownership: Direct

2026-03-19Sale

Owner: Moore, Michael

Title: President

Shares: 40,232

Price/Share: $9.21

Value: $370,536.72

Shares Owned: 1,650,812

Relationship: Officer

Ownership: Indirect

2025-08-13Sale

Owner: Cambre, Jerome

Title: Vice President of Sales

Shares: 4,880

Price/Share: $7.32

Value: $35,721.60

Shares Owned: 84,191

Relationship: Officer

Ownership: Direct

2025-08-12Sale

Owner: Moore, Michael

Title: President

Shares: 50,090

Price/Share: $7.33

Value: $367,159.70

Shares Owned: 126,343

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-25	Frazier, William	Director,Officer	Chief Medical Officer	Direct	Sale	10,000	11.72	$117,200.00	73,214	4
2026-06-24	Smokoff, Timothy	Director	-	Direct	Sale	20,000	11.50	$230,000.00	75,518	4
2026-03-19	Moore, Michael	Officer	President	Indirect	Sale	40,232	9.21	$370,536.72	1,650,812	4
2025-08-13	Cambre, Jerome	Officer	Vice President of Sales	Direct	Sale	4,880	7.32	$35,721.60	84,191	4
2025-08-12	Moore, Michael	Officer	President	Direct	Sale	50,090	7.33	$367,159.70	126,343	4
2025-06-30	Moore, Michael	Officer	President	Direct	Sale	177,830	6.92	$1,230,583.60	177,433	4
2025-06-30	Kaushal, Nitin	Director	-	Direct	Sale	7,048	6.91	$48,701.68	126,843	4
2025-06-27	Kaushal, Nitin	Director	-	Direct	Sale	34,100	7.01	$239,041.00	126,843	4
2025-03-14	Smokoff, Timothy	Director	-	Direct	Sale	3,000	7.73	$23,190.00	79,786	4
2024-11-26	Kaushal, Nitin	Director	-	Direct	Sale	5,995	8.58	$51,437.10	126,843	4
2024-11-20	Kaushal, Nitin	Director	-	Direct	Sale	15,000	8.50	$127,500.00	126,843	4
2024-11-13	Kaushal, Nitin	Director	-	Direct	Sale	30,000	9.48	$284,400.00	126,843	4
2024-11-13	Dobbs, Randy E.	Director	-	Direct	Sale	36,261	9.28	$336,502.08	107,706	4
2024-05-14	Heltz, Sabrina	Director	-	Direct	Purchase	2,820	7.06	$19,909.20	41,040	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

63.09%

Inst. Shares: 24,243,595

Shares Outstanding: 38,428,588

2025-12-31

59.71%

Inst. Shares: 23,223,767

Shares Outstanding: 38,895,228

2025-09-30

61.30%

Inst. Shares: 23,686,008

Shares Outstanding: 38,638,660

2025-06-30

60.58%

Inst. Shares: 23,938,769

Shares Outstanding: 39,515,247

2025-03-31

55.05%

Inst. Shares: 21,705,220

Shares Outstanding: 39,426,753

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	24,243,595	38,428,588	63.09%
2025-12-31	23,223,767	38,895,228	59.71%
2025-09-30	23,686,008	38,638,660	61.30%
2025-06-30	23,938,769	39,515,247	60.58%
2025-03-31	21,705,220	39,426,753	55.05%
2024-12-31	21,336,106	38,754,893	55.05%
2024-09-30	21,245,025	38,870,823	54.66%
2024-06-30	21,041,205	38,822,980	54.20%
2024-03-31	20,225,488	38,717,123	52.24%
2023-12-31	17,585,253	38,354,071	45.85%
2023-09-30	18,457,577	38,438,058	48.02%
2023-06-30	19,278,903	38,324,249	50.30%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

VIEMED HEALTHCARE, INC. (VMD) — SEC Financial Statements & Analysis

VIEMED HEALTHCARE, INC. (VMD) is a services-misc health & allied services, nec company, incorporated in A1. VIEMED HEALTHCARE, INC. trades on Nasdaq as: VMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), VIEMED HEALTHCARE, INC. reported a 23.10% year-over-year revenue growth, a Gross Profit Margin of 57.58% (TTM), a Debt-to-Equity ratio of 0.35x, a Price-to-Sales (P/S) ratio of 1.24x (TTM), a Price-to-Book (P/B) ratio of 2.43 (TTM), at a market cap of $353.93M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 23.10%
Gross Profit Margin TTM: 57.58%
Debt To Equity: 0.35x
P/S TTM: 1.24x
P/B TTM: 2.43
Market Cap: $353.93M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is VIEMED HEALTHCARE, INC. in?

VIEMED HEALTHCARE, INC. (VMD) operates in the Services-Misc Health & Allied Services, NEC industry.

What is VMD's market cap?

VIEMED HEALTHCARE, INC. (VMD) has a market capitalization of $353.93M as of 2026-03-31.

What is VMD's P/E ratio?

VIEMED HEALTHCARE, INC. (VMD)'s trailing twelve month P/E ratio is 23.08x as of 2026-03-31.

What exchange does VMD trade on?

VIEMED HEALTHCARE, INC. (VMD) trades on the Nasdaq.

Where is VIEMED HEALTHCARE, INC. incorporated?

VIEMED HEALTHCARE, INC. is incorporated in British Columbia, Canada.

VIEMED HEALTHCARE, INC. (VMD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.